1/16
10:57 am
cc
Chemours (NYSE:CC) had its "outperform" rating reaffirmed by analysts at Royal Bank Of Canada.
Medium
Report
Chemours (NYSE:CC) had its "outperform" rating reaffirmed by analysts at Royal Bank Of Canada.
1/15
05:32 pm
cc
The Chemours Company Agrees to Sell Former Titanium Dioxide Site in Taiwan [Yahoo! Finance]
Low
Report
The Chemours Company Agrees to Sell Former Titanium Dioxide Site in Taiwan [Yahoo! Finance]
1/15
05:01 pm
cc
The Chemours Company Agrees to Sell Former Titanium Dioxide Site in Taiwan
Low
Report
The Chemours Company Agrees to Sell Former Titanium Dioxide Site in Taiwan
12/22
02:01 pm
cc
This Chemicals Stock Is Down 32% but Just Became a Top 5 Holding After One Fund's $13 Million Bet [Yahoo! Finance]
Low
Report
This Chemicals Stock Is Down 32% but Just Became a Top 5 Holding After One Fund's $13 Million Bet [Yahoo! Finance]
12/16
12:04 pm
cc
Fluoroelastomers (FKM) Market Size to Reach a Valuation of USD 2.79 Billion by 2033; High Demand for FKM from Automotive Industry to Augment Market Expansion [Yahoo! Finance]
Low
Report
Fluoroelastomers (FKM) Market Size to Reach a Valuation of USD 2.79 Billion by 2033; High Demand for FKM from Automotive Industry to Augment Market Expansion [Yahoo! Finance]
12/14
11:53 pm
cc
Chemours Company (CC) Up More than 12% Since Q3, Here's What Wall Street Thinks About the Stock [Yahoo! Finance]
Medium
Report
Chemours Company (CC) Up More than 12% Since Q3, Here's What Wall Street Thinks About the Stock [Yahoo! Finance]
12/9
02:33 am
cc
JPMorgan Reduces PT on The Chemours Company (CC) to $13 From $15, Keeps a Neutral Rating [Yahoo! Finance]
Neutral
Report
JPMorgan Reduces PT on The Chemours Company (CC) to $13 From $15, Keeps a Neutral Rating [Yahoo! Finance]
12/4
04:30 pm
cc
Chemours Appoints Michael Foley as President of Titanium Technologies; Announces Departure of Damián Gumpel
Low
Report
Chemours Appoints Michael Foley as President of Titanium Technologies; Announces Departure of Damián Gumpel
12/3
11:23 am
cc
Chemours (NYSE:CC) had its price target lowered by analysts at JPMorgan Chase & Co. from $15.00 to $13.00. They now have a "neutral" rating on the stock.
Low
Report
Chemours (NYSE:CC) had its price target lowered by analysts at JPMorgan Chase & Co. from $15.00 to $13.00. They now have a "neutral" rating on the stock.
11/11
03:59 pm
cc
Chemours (NYSE:CC) had its price target lowered by analysts at UBS Group AG from $21.00 to $18.00. They now have a "buy" rating on the stock.
Low
Report
Chemours (NYSE:CC) had its price target lowered by analysts at UBS Group AG from $21.00 to $18.00. They now have a "buy" rating on the stock.
11/10
12:53 pm
cc
Chemours (NYSE:CC) had its price target lowered by analysts at Truist Financial Corporation from $21.00 to $18.00. They now have a "buy" rating on the stock.
Low
Report
Chemours (NYSE:CC) had its price target lowered by analysts at Truist Financial Corporation from $21.00 to $18.00. They now have a "buy" rating on the stock.
11/10
11:09 am
cc
Chemours (NYSE:CC) had its price target lowered by analysts at Royal Bank Of Canada from $19.00 to $17.00. They now have an "outperform" rating on the stock.
Low
Report
Chemours (NYSE:CC) had its price target lowered by analysts at Royal Bank Of Canada from $19.00 to $17.00. They now have an "outperform" rating on the stock.
11/6
04:30 pm
cc
The Chemours Company Reports Third Quarter 2025 Results
High
Report
The Chemours Company Reports Third Quarter 2025 Results
10/29
05:00 pm
cc
Chemours Announces Fourth Quarter Dividend
Medium
Report
Chemours Announces Fourth Quarter Dividend
10/21
07:27 am
cc
Chemours (NYSE:CC) was downgraded by analysts at Zacks Research from a "hold" rating to a "strong sell" rating.
Low
Report
Chemours (NYSE:CC) was downgraded by analysts at Zacks Research from a "hold" rating to a "strong sell" rating.